vimarsana.com
  • Home
  • Live Updates
  • New collaboration could advance small molecule epilepsy therapy : comparemela.com

    • New collaboration could advance small molecule epilepsy therapy

    UCB and Praxis Precision Medicines, Inc. will collaborate to advance Praxis’ PRAX-020 small molecule programme for KCNT1 related epilepsies.

    Related Keywords

    Marcio Souza , Praxis Precision Medicines Inc , Praxis Precision Medicines , Chief Executive Officer ,

    © 2024 Vimarsana

    comparemela.com © 2020. All Rights Reserved.